A selective inhibitor of the immunoproteasome subunit LMP2 induces apoptosis in PC-3 cells and suppresses tumour growth in nude mice
出版年份 2012 全文链接
标题
A selective inhibitor of the immunoproteasome subunit LMP2 induces apoptosis in PC-3 cells and suppresses tumour growth in nude mice
作者
关键词
-
出版物
BRITISH JOURNAL OF CANCER
Volume 107, Issue 1, Pages 53-62
出版商
Springer Nature
发表日期
2012-06-08
DOI
10.1038/bjc.2012.243
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Nonproteasomal Targets of the Proteasome Inhibitors Bortezomib and Carfilzomib: a Link to Clinical Adverse Events
- (2011) S. Arastu-Kapur et al. CLINICAL CANCER RESEARCH
- Second Generation Proteasome Inhibitors: Carfilzomib and Immunoproteasome-Specific Inhibitors (IPSIs)
- (2011) D. J. Kuhn et al. CURRENT CANCER DRUG TARGETS
- Immunoproteasomes Preserve Protein Homeostasis upon Interferon-Induced Oxidative Stress
- (2010) Ulrike Seifert et al. CELL
- Proteasome Inhibitors: Recent Advances and New Perspectives In Medicinal Chemistry
- (2010) E. Genin et al. CURRENT TOPICS IN MEDICINAL CHEMISTRY
- Targeting the proteasome: partial inhibition of the proteasome by bortezomib or deletion of the immunosubunit LMP7 attenuates experimental colitis
- (2010) N. Schmidt et al. GUT
- Thymoproteasome Shapes Immunocompetent Repertoire of CD8+ T Cells
- (2010) Takeshi Nitta et al. IMMUNITY
- Prevention of Experimental Colitis by a Selective Inhibitor of the Immunoproteasome
- (2010) M. Basler et al. JOURNAL OF IMMUNOLOGY
- Bortezomib Sensitizes Human Esophageal Squamous Cell Carcinoma Cells to TRAIL-Mediated Apoptosis via Activation of Both Extrinsic and Intrinsic Apoptosis Pathways
- (2010) N. Seki et al. MOLECULAR CANCER THERAPEUTICS
- Two abundant proteasome subtypes that uniquely process some antigens presented by HLA class I molecules
- (2010) B. Guillaume et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- NFκB signaling in carcinogenesis and as a potential molecular target for cancer therapy
- (2009) Han-Ming Shen et al. APOPTOSIS
- Carfilzomib can induce tumor cell death through selective inhibition of the chymotrypsin-like activity of the proteasome
- (2009) F. Parlati et al. BLOOD
- The Biological Functions of NF-κB1 (p ) and its Potential as an Anti-Cancer Target
- (2009) Yonghui Yu et al. CURRENT CANCER DRUG TARGETS
- No Splicing, No Dicing: Non-proteolytic Roles of the Ubiquitin-Proteasome System in Transcription
- (2009) Thomas Kodadek JOURNAL OF BIOLOGICAL CHEMISTRY
- Obovatol Enhances Docetaxel-Induced Prostate and Colon Cancer Cell Death Through Inactivation of Nuclear Transcription Factor-κB
- (2009) So Yong Lee et al. JOURNAL OF PHARMACOLOGICAL SCIENCES
- A selective inhibitor of the immunoproteasome subunit LMP7 blocks cytokine production and attenuates progression of experimental arthritis
- (2009) Tony Muchamuel et al. NATURE MEDICINE
- Targeted inhibition of the immunoproteasome is a potent strategy against models of multiple myeloma that overcomes resistance to conventional drugs and nonspecific proteasome inhibitors
- (2008) Deborah J. Kuhn et al. BLOOD
- Bortezomib-induced peripheral neuropathy in multiple myeloma: a comprehensive review of the literature
- (2008) A. A. Argyriou et al. BLOOD
- The role of the NFκB signalling pathway in cancer
- (2008) María Cortés Sempere et al. Clinical & Translational Oncology
- Bortezomib-Mediated Inhibition of Steroid Receptor Coactivator-3 Degradation Leads to Activated Akt
- (2008) G. Ayala et al. CLINICAL CANCER RESEARCH
- Proteasome modulators: essential chemical genetic tools for understanding human diseases
- (2008) Marie Wehenkel et al. Molecular BioSystems
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More